🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare 6-month treatment outcomes for 15-2...
Status
Completed
Location
Friends Research Institute
Start Date
2013-06
Trial ID
NCT01843023
Treatments Being Tested
This was a study of the effects of VIVITROL® on alcohol cue-induced craving...
Status
Completed
Location
McLean Hospital
Start Date
2007-07
Trial ID
NCT00511836
Treatments Being Tested
PF614 is an oxycodone prodrug that is designed for extended-release of oxyc...
Status
Completed
Location
PRA Health Sciences - Early Development Services
Start Date
2016-11-16
Trial ID
NCT02454712
Treatments Being Tested
This is an observational cohort study using administrative insurance claims...
Status
Enrolling By Invitation
Location
IBM Watson Health™ Truven Marketscan
Start Date
2020-02-01
Trial ID
NCT05503927
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of Me...
Status
Completed
Location
Alkermes Clinical Study Site
Start Date
2009-03
Trial ID
NCT00834080
Treatments Being Tested
The aim of this study is to investigate the safety and effectiveness of bup...
Status
Completed
Location
UCLA Integrated Substance Abuse Programs (ISAP)
Start Date
2011-09
Trial ID
NCT01402492
Treatments Being Tested
This study seeks to compare the effectiveness of two medications used to tr...
Status
Completed
Location
Yale University School of Medicine
Start Date
2021-01-07
Trial ID
NCT04219540
Treatments Being Tested
This is a double-blind, placebo-controlled, randomized clinical trial evalu...
Status
Completed
Location
University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM)
Start Date
2017-05-05
Trial ID
NCT03078075
Treatments Being Tested
This study aims to determine if low-dose naltrexone (LDN) reduces fatigue, ...
Status
Completed
Location
Women's Health Research Institute
Start Date
2024-01-15
Trial ID
NCT05430152
Treatments Being Tested
Naltrexone is a medication that has been shown to help prevent relapse to o...
Status
Completed
Location
Rhode Island Hospital
Start Date
2012-03
Trial ID
NCT01563718
Treatments Being Tested